A survey on the structure, organization, and functions of medical information departments in the pharmaceutical industry in Spain
The medical information (MI) function within the pharmaceutical industry plays a significant role in the provision of scientific answers for patients and healthcare professionals. The purpose of this study is to identify the current structure, organization, and functions of MI departments in Spain. Sixty local and international pharmaceutical companies based in Spain were invited to participate in this study between May and July 2019. An online 34–item questionnaire developed by the AMIFE MI Working Group was distributed to the companies. Data were analyzed through descriptive statistics using response frequencies. A total of 44 responses from 60 surveys (73%) were received. More than half of the respondents were employed in international companies based in Europe (57%, n = 25). Seventy-one percent (n = 31) of the companies had 100 to 1,000 employees in Spain. Most respondents declared that they had an MI department in their company (73%, n = 32), with most (53%) having two to five employees working on MI. Most MI (n = 50) specialists had a biomedical academic degree (predominantly pharmacy, biology, and medicine). MI departments were involved in many functions, the most common being answering enquiries (100%), handling drug information requests (97%), preparing written responses (94%), and literature services for external use (77%). The mean annual volume of MI enquiries was 2,301 (median 1,100). The results of this survey contribute to a better understanding of MI departments in Spanish pharmaceutical companies, as well as their functions and responsibilities, and could help identify opportunities and areas for improvement.
Albano, Dominick; Soloff, Allison; Heim, Katelyn; Mavila, Sudeep (2016). “A theory on the relativity of factors impacting the utilization of medical information services from the pharmaceutical industry”. Therapeutic innovation & regulatory science, v. 50, n. 5, pp. 554-559. https://doi.org/10.1177/2168479016640019
Best Practices; LLC’s Research; Advisory Services (2018). Medical information excellence: building capabilities for better internal & external communication. White paper. Chapel Hill.
Bonk, Lisa; Kothari, Madhuri; Andrikanich, Alyson-Sous; Yang, Ellen (2012). “The role of pharmaceutical medical information in promotional review: three benchmarking surveys”. Drug information journal, v. 46, n. 1, pp. 107-114. https://doi.org/10.1177/0092861511427873
Bordoloi, Poonam; Gažo, Andrew; Savulich, Donna; Verzosa, Conrad (2014). “Medical information services: How are we trending?”. Therapeutic innovation & regulatory science, v. 48, n. 6, pp. NP15-NP21. https://doi.org/10.1177/2168479014546334
EFPIA (2019). EFPIA HCP Code. EFPIA code on the promotion of prescription-only medicines to, and interactions with, health-care professionals. General Assembly Consolidated Final. EFPIA; 2019. Final consolidated version; 2019. June 27 final editing, pp. 1-59. European Federation of Pharmaceutical Industries and Associations. https://www.efpia.eu/media/554677/efpia_codes_a5_v3-2021_sm.pdf
European Parliament (2001). “Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use”. Official journal of the European Communities, Nov 28, pp. L 311/67-128. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:311:0067:0128:en:PDF
Flores, Ángela; Balmy, Sylvaine; Rojo, Mónica; Ortega, Patricia; Cabo, Lurdes; Carboneras, Marta; Del-Cano, Marta; Escudero, Nuria; Fragoso, Jaime; García-Ortiz, Daniel; Iglesias, Inmaculada; Pozo, Tamara; Pulido, Fernanda; Rodríguez, Mónica; Sánchez-Navarro María-José (2015). “Descriptive analysis of Medical Information departments within the pharmaceutical industry in Spain”. In: 9th Annual European medical information and communications conference and exhibition. https://www.researchgate.net/publication/284189078_Descriptive_Analysis_of_Medical_Information_Departments_within_the_Pharmaceutical_Industry_in_Spain
Guardiola, Elena; Flores, Ángeles; Balmy, Sylvaine; Rojo, Mónica; Ortega, Patricia; Cabo, Lurdes; Del-Cano, Marta; Escudero, Nuria; Fragoso, Jaime; García-Ortiz, Daniel; Iglesias, Inmaculada; Pozo, Tamara; Pulido, Fernanda; Rodríguez-Sangrador, Mónica; Sánchez-Navarro, María-José (2016). “Structure, organization and functions of medical information departments within the pharmaceutical industry in Spain: Results of a survey”. In: 15th European Association for Health Information and Libraries (EAHIL) Conference, pp. 12-13. http://old.eahil.eu/conferences/2016Seville/www.bvsspa.es/eahil2016/wp-content/uploads/2016/06/J1p.pdf
Guillot, Pete; Fung, Stacey M. (2010). “Pharmaceutical medical information contact centers: results of three benchmarking surveys”. Drug information journal, v. 44, n. 5, pp. 569-579. https://doi.org/10.1177/009286151004400504
Health Information and Quality Authority (2013). Guidance on developing key performance indicators and minimum data sets to monitor healthcare quality. Version 1.2. Dublin: Health Information and Quality Authority. https://www.hiqa.ie/sites/default/files/2017-01/KPI-Guidance-Version1.1-2013.pdf
Khan, Sadia; Bawden, David (2000). “Quality standards in drug and medical information departments”. Aslib proceedings, v. 52, n.4, pp. 134-142. https://doi.org/10.1108/EUM0000000007008
Leighton, Sharon; Davies, Janet E. (2009). “Surveying medical information across Europe: The present and the future”. Drug information journal, v. 43, n. 5, pp. 637-654. https://doi.org/10.1177/009286150904300602
Marasigan, Kirstie; Doshi, Sara; Fung, Stacey (2020). “Pharma collaboration for transparent medical information (phactMI™) benchmark study: Results of organizational structure and resourcing of medical information services in support of building departmental strategies”. Therapeutic innovation & regulatory science, n. 54, pp. 1269–1274. https://doi.org/10.1007/s43441-020-00143-1
Nguyen, Cambrey (2018). “The non-traditional role: Pharmacists in medical information”. En: DIA 2018 Global Annual Meeting. T-16. https://www.diaglobal.org/Tools/Content.aspx?type=eopdf&file=/productfiles/6589208/18001_final_program.pdf
Nguyen, Cambrey (2020). “The role of a pharmacist as a medical information specialist in the pharmaceutical industry”. Currents in pharmacy teaching and learning, v. 12, n. 2, pp. 127-131. https://doi.org/10.1016/j.cptl.2019.11.005
Ogbru, Ome (2014). Medical information role in the pharmaceutical industry. White paper. Coral Gables, FL: ArisGlobal. https://docplayer.net/16061727-Medical-information-role-in-the-pharmaceutical-industry.html
Patel, Meera; Jindia, Leena; Fung, Stacey; Kadowaki, Richard; Marasigan, Kirstie (2020). “Pharma collaboration for transparent medical information (phactMI™) benchmark study: Trends, drivers, and value of product support activities, key performance indicators, and other medical information services: Insights from a survey of 27 US pharmaceutical medical information departments”. Therapeutic innovation & regulatory science, n. 54, pp. 1275–1281. https://doi.org/10.1007/s43441-020-00162-y
Roberts, Glynne (2000). “Medical information in the UK pharmaceutical industry”. International journal of pharmaceutical medicine, v. 14, n. 3, pp. 159-162. https://link.springer.com/article/10.1097/00124363-200006000-00009
Robson, Andrew S.; Blake, Jennifer; Chandler, Rita; Dallamy, L.; Davies, Jonathan; Fleming, Karen; Leighton, Sharon; Roberts, Glynne; Robson, David; Simister, Katrina; Taylor, Johanna (1996). “Medical information services in the pharmaceutical industry: a survey of pharmacists’ views with recommendations”. Pharmaceutical journal, v. 256, pp. 864-866.
Robson, Andrew S.; Robson, David (2000). “Industry-based medical information in Europe: Practices and customer expectations”. Drug information journal, v. 34, n. 4, pp. 1089-1095. https://doi.org/10.1177/009286150003400414
Soares, Stacey C.; Marsh, Christi (2008). “Metrics implementation in an industry-based medical information department and comparison to metrics tracked within other industry-based medical information departments”. Drug information journal, v. 42, n. 2, pp. 175-182. https://doi.org/10.1177/009286150804200209
Stonier, Peter D. (2003). Careers with the pharmaceutical industry. Chichester: Wiley, ISBN: 978 0 470 01372 4
Tabuenca-Cortés, María; Casas-Gálvez, I.; Fragoso-de-Castro, Jaime; Oyagüez-Martín, I.; (2004). “La información médica en el entorno de la industria farmacéutica en España”. In: XXIV Symposium AEFI. Pharmaceutical Innovation in the new Europe.
TenBarge, Andrea M.; Riggins, Jennifer L. (2018). “Responding to unsolicited medical requests from health care professionals on pharmaceutical industry-owned social media sites: Three pilot studies”. Journal of medical internet research, v. 20, n. 10, pp. e285. https://doi.org/10.2196/jmir.9643
Werner, Amy L.; Poe, Timothy E.; Graham, James A. (2000). “Expanding medical communications services to internal customers”. Drug information journal, v. 34, n. 4, pp. 1053-1061. https://doi.org/10.1177/009286150003400409
Wormleighton, Charlotte; Leighton, Sharon (2009). “Auditing medical information services across Western Europe a cost-effective approach”. Drug information journal, v. 43, n. 6, pp. 655-662. https://doi.org/10.1177/009286150904300603
Wu, Kimberly; Smith-Schmelz, Laura; Doshi, Sara M. (2013). “Medical information specialists: Benchmarks in practice”. Therapeutic innovation & regulatory science, v. 47, n. 2, pp. 190-197. https://doi.org/10.1177/2168479012461442